Targeted disruption of the p50 subunit of NF-κB reduces atherosclerotic lesions with an inflammatory phenotype as well as ventricular rupture after myocardial infarction, a proinflammatory disease [51,52]. This evidence concerns the gene NFKB1 and myocardial infarction.